Investor Relations

Press Releases

All Releases
View Summary OPKO Health to Present at the Jefferies 2015 Healthcare Conference
May 27, 2015
PDF 9.1 KB
View Summary OPKO Announces 4Kscore® Abstracts at the 2015 American Urological Association (AUA) Annual Meeting
May 18, 2015
PDF 13.1 KB
View Summary OPKO Announces Publication of Study Using Kallikrein Biomarkers of the 4Kscore® Test in a Large Community-Based Referral Cohort
May 15, 2015
PDF 13.2 KB
View Summary OPKO Announces First Quarter Operating and Financial Results
May 11, 2015
PDF 72.9 KB
View Summary CORRECTING and REPLACING OPKO To Announce First Quarter Financial Results on May 11, 2015
May 7, 2015
PDF 10.5 KB
View Summary OPKO To Announce First Quarter Financial Results on May 11, 2015
May 7, 2015
PDF 10.3 KB
View Summary OPKO Health Acquires EirGen Pharma
May 5, 2015
PDF 12.1 KB
View Summary OPKO Announces Publication of ProtecT Study Using Kallikrein Biomarkers in 4Kscore Test
Apr 21, 2015
PDF 61.6 KB
View Summary Conversion Right Triggered on OPKO 3.0% Convertible Senior Notes
Apr 1, 2015
PDF 10.2 KB
View Summary Phase 3 Data Supporting Rayaldee™ As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at NKF 2015 Spring Clinical Meetings
Mar 27, 2015
PDF 12.9 KB
View Summary OPKO Investee SciVac Ltd. Enters into Transaction with Levon Resources
Mar 23, 2015
PDF 11.1 KB
View Summary OPKO Lab Receives Accreditation From College of American Pathologists
Mar 18, 2015
PDF 13.3 KB
View Summary Phase 3 Data Supporting Rayaldee As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at ENDO 2015 Conference
Mar 6, 2015
PDF 12.7 KB
View Summary Twelve Months Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at ENDO 2015 Conference
Mar 3, 2015
PDF 12.5 KB
View Summary OPKO Announces Fourth Quarter Operating and Financial Results
Feb 27, 2015
PDF 26.7 KB
View Summary OPKO to Announce Fourth Quarter and Full Year 2014 Financial Results on February 27, 2015
Feb 26, 2015
PDF 10.4 KB
View Summary OPKO Announces Publication of 20 Year Outcome Study for Lethal Prostate Cancer Using Kallikrein Biomarkers in 4Kscore Test
Feb 20, 2015
PDF 13.4 KB
View Summary OPKO Health to Present at the 2015 RBC Capital Markets' Healthcare Conference
Feb 13, 2015
PDF 8.5 KB
View Summary OPKO Submits Investigational New Drug Application to Initiate a Phase 2a Trial for its Long-Acting Coagulation Factor VIIa-CTP to Treat Hemophilia
Jan 30, 2015
PDF 11.8 KB
View Summary OPKO and Pfizer Receive Regulatory Clearance for Global Agreement
Jan 29, 2015
PDF 9.7 KB
Showing 1-20 of 217 Page: 1 2 3 4 5 ... 11  Next 20